Delivery Order SPE2DB22D3019-SPE2DB24FK2UX
Award Date 12/11/23
Potential Completion Date 12/12/23
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,252.35 firm fixed-price delivery order is for the supply of PROGRAF 5 MG CAPSULE 100S, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,752.52, is for the delivery of Prograf 1 mg capsules, a medication used for organ transplant patients. The contract is a firm fixed-price, non-set-aside award with a performance period through April 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $4,732.79 and is a Delivery Order for the product "PROGRAF 1 MG CAPSULE 100S". The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
- This federal contract award, with an award ID of SPE2DB24D1205|SPE2DB24FCUQB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The award is for the delivery of the pharmaceutical product Prograf 1 mg capsule, in quantities of 100 per bottle. The contract has a firm fixed price of $6,764.62 and an ultimate completion date of September 12, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, through its...
- The Defense Logistics Agency awarded a delivery order valued at $27,638.41 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) with a completion date of August 25, 2025. This is a firm fixed-price delivery order under a non-set-aside competition, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills...
- This federal contract award is a delivery order (SPE2DB20D2014|SPE2DB24FA70B) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,107.49 contract is for the provision of PROGRAF 1 MG CAPSULE 100S, a specialty medication, with a performance period through January 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award, valued at $5,037.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROGRAF 5 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through March 7, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price valued at $1,522.32 and a performance period through November 6, 2024. The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, a Delivery Order valued at $1,107.95, is for the supply of PROGRAF 0.5 MG CAPSULE 100S, a prescription medication. The contract has a Firm Fixed Price pricing type and a completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,326.84 and covers the delivery of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, through September 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB24FK2UXDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of the drug Prograf (tacrolimus) 5 mg capsules. The contract, valued at $14,053.85, is a Firm Fixed Price Delivery Order with a period of performance through December 12, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated as a set-aside procurement.
Generated 5/12/25, 10:00 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 12/11/23 |